Anavex Life Sciences (AVXL) Net Income Growth (5y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.28% |
| Sep 30, 2025 | -12.70% |
| Jun 30, 2025 | -17.39% |
| Mar 31, 2025 | -11.57% |
| Dec 31, 2024 | -15.57% |
| Sep 30, 2024 | -15.94% |
| Jun 30, 2024 | -13.37% |
| Mar 31, 2024 | -7.79% |
| Dec 31, 2023 | -4.50% |
| Sep 30, 2023 | -12.65% |
| Jun 30, 2023 | -31.68% |
| Mar 31, 2023 | -22.50% |
| Dec 31, 2022 | -26.16% |
| Sep 30, 2022 | -22.62% |
| Jun 30, 2022 | -27.92% |
| Mar 31, 2022 | -46.46% |
| Dec 31, 2021 | -28.17% |
| Sep 30, 2021 | -12.47% |
| Jun 30, 2021 | -35.36% |